Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine A Shu

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2021
What Is Neo? Chemoimmunotherapy in the Neoadjuvant Setting for Resectable Non-Small-Cell Lung CancerCatherine A Shu, Tina Cascone
The Oncologist|January 21, 2015
Breaking down the evidence for bevacizumab in ovarian cancerCatherine A Shu, Jason A Konner
The Oncologist|March 31, 2016
Into the Clinic With Nivolumab and PembrolizumabCatherine A Shu, Naiyer A Rizvi
Psycho-Oncology|January 28, 2024
A case study on severe psychiatric symptoms induced by lorlatinibMichael A Liu, Eleanor Xu, Catherine A Shu
Annals of Translational Medicine|October 24, 2017
PD-L1 as a biomarker in NSCLC: challenges and future directionsMatthen Mathew, Rachael A Safyan, Catherine A Shu
Therapeutic Advances in Medical Oncology|April 3, 2023
Neoadjuvant immunotherapy in resectable non-small-cell lung cancerLanyi Nora Chen, Alexander Z Wei, Catherine A Shu
JAMA Oncology|November 11, 2016
Reservations About Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations-ReplyCatherine A Shu, Malcolm C Pike, Noah D Kauff
Pharmacology & Therapeutics|January 22, 2018
Combining chemotherapy with PD-1 blockade in NSCLCMatthen Mathew, Thomas Enzler, Catherine A Shu, et al.
JTO Clinical and Research Reports|September 30, 2021
Hepatoid Adenocarcinoma of the Lung Responsive to Frontline Combination Chemotherapy With Immunotherapy: Case ReportGalina G Lagos, Jarett L Feldman, Anjali Saqi, et al.
Diagnostic Cytopathology|April 30, 2020
Pulmonary small cell carcinoma: Review, common and uncommon differentials, genomics and managementSimon Sung, Maryam Shirazi, Catherine A Shu, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2021
What Is Neo? Chemoimmunotherapy in the Neoadjuvant Setting for Resectable Non-Small-Cell Lung CancerCatherine A Shu, Tina Cascone
The Oncologist|January 21, 2015
Breaking down the evidence for bevacizumab in ovarian cancerCatherine A Shu, Jason A Konner
The Oncologist|March 31, 2016
Into the Clinic With Nivolumab and PembrolizumabCatherine A Shu, Naiyer A Rizvi
Psycho-Oncology|January 28, 2024
A case study on severe psychiatric symptoms induced by lorlatinibMichael A Liu, Eleanor Xu, Catherine A Shu
Annals of Translational Medicine|October 24, 2017
PD-L1 as a biomarker in NSCLC: challenges and future directionsMatthen Mathew, Rachael A Safyan, Catherine A Shu
Therapeutic Advances in Medical Oncology|April 3, 2023
Neoadjuvant immunotherapy in resectable non-small-cell lung cancerLanyi Nora Chen, Alexander Z Wei, Catherine A Shu
JAMA Oncology|November 11, 2016
Reservations About Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations-ReplyCatherine A Shu, Malcolm C Pike, Noah D Kauff
Pharmacology & Therapeutics|January 22, 2018
Combining chemotherapy with PD-1 blockade in NSCLCMatthen Mathew, Thomas Enzler, Catherine A Shu, et al.
JTO Clinical and Research Reports|September 30, 2021
Hepatoid Adenocarcinoma of the Lung Responsive to Frontline Combination Chemotherapy With Immunotherapy: Case ReportGalina G Lagos, Jarett L Feldman, Anjali Saqi, et al.
Diagnostic Cytopathology|April 30, 2020
Pulmonary small cell carcinoma: Review, common and uncommon differentials, genomics and managementSimon Sung, Maryam Shirazi, Catherine A Shu, et al.
Pageof 5